Company InfoNewsInvestor InformationResearchDevelopmentCareersBusiness DevelopmentResourcesDrugs databaseBack to the home pageSearch  
Drugs database
Drugs A-Z

Brands A-Z

Drugs by categories

Drugs by manufacturer

Drugs by packager

Antibiotics for sale

Online Viagra bestellen in Nederland

Home / Drugs / Starting with O / Ondansetron

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. [PubChem]
Sandoz ondansetron
Zofran ODT
CategoriesAnti-anxiety Agents
Serotonin Antagonists
Antipsychotic Agents
ManufacturersPar pharmaceutical
Aurobindo pharma ltd
Barr laboratories inc
Glenmark generics ltd
Kv pharmaceutical co
Mylan pharmaceuticals inc
Par pharmaceutical inc
Sandoz inc
Sun pharmaceutical industries ltd
Teva pharmaceuticals usa inc
Akorn strides llc
Apotex inc
App pharmaceuticals llc
Baxter healthcare corp anesthesia and critical care
Bedford laboratories div ben venue laboratories inc
Emcure pharmaceuticals ltd
Gland pharma ltd
Hikma farmaceutica (portugal) sa
Hospira inc
Lannett holdings inc
Luitpold pharmaceuticals inc
Pharmaforce inc
Pliva hrvatska doo
Sandoz canada inc
Spectrum pharmaceuticals
Wockhardt ltd
Bedford laboratories
Claris lifesciences ltd
Teva parenteral medicines inc
Baxter healthcare corp
Apotex inc richmond hill
Taro pharmaceuticals ireland ltd
Roxane laboratories inc
Taro pharmaceutical industries ltd
Dr reddys laboratories ltd
Natco pharma ltd
West ward pharmaceutical corp
PackagersAceto Pharma Inc.
Actavis Group
Aidarex Pharmacuticals LLC
Akorn Inc.
Amerigen Pharmaceuticals Inc.
Apotex Inc.
Apotheca Inc.
APP Pharmaceuticals
A-S Medication Solutions LLC
Ascend Laboratories LLC
Atlantic Biologicals Corporation
Aurobindo Pharma Ltd.
Baxter International Inc.
Bedford Labs
Ben Venue Laboratories Inc.
Cardinal Health
Catalent Pharma Solutions
Claris Lifesciences Inc.
Cura Pharmaceutical Co. Inc.
Dispensing Solutions
Diversified Healthcare Services Inc.
Doctor Reddys Laboratories Ltd.
Emcure Pharmaceuticals Ltd.
Ethex Corp.
GlaxoSmithKline Inc.
Glenmark Generics Ltd.
Greenstone LLC
Hikma Pharmaceuticals
Hospira Inc.
Kaiser Foundation Hospital
Kali Laboratories Inc.
Lake Erie Medical and Surgical Supply
Lannett Co. Inc.
Murfreesboro Pharmaceutical Nursing Supply
Natco Pharma Ltd.
Northstar Rx LLC
Nucare Pharmaceuticals Inc.
PD-Rx Pharmaceuticals Inc.
Penn Labs
Pfizer Inc.
Physicians Total Care Inc.
Pliva Inc.
Preferred Pharmaceuticals Inc.
Professional Co.
Ranbaxy Laboratories
Rebel Distributors Corp.
Redpharm Drug
Roxane Labs
Sagent Pharmaceuticals
Southwood Pharmaceuticals
Stat Rx Usa
Strides Arcolab Limited
Sun Pharmaceutical Industries Ltd.
Taro Pharmaceuticals USA
Teva Pharmaceutical Industries Ltd.
UDL Laboratories
Watson Pharmaceuticals
West-Ward Pharmaceuticals
Wockhardt Ltd.


For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, postoperation, and radiation. Also used for the treatment of postoperative nausea and vomiting.


Ondansetron is a highly specific and selective serotonin 5-HT3 receptor antagonist, not shown to have activity at other known serotonin receptors and with low affinity for dopamine receptors. The serontonin 5-HT3 receptors are located on the nerve terminals of the vagus in the periphery, and centrally in the chemoreceptor trigger zone of the area postrema. The temporal relationship between the emetogenic action of emetogenic drugs and the release of serotonin, as well as the efficacy of antiemetic agents suggest that chemotherapeutic agents release serotonin from the enterochromaffin cells of the small intestine by causing degenerative changes in the GI tract. The serotonin then stimulates the vagal and splanchnic nerve receptors that project to the medullary vomiting center, as well as the 5-HT3 receptors in the area postrema, thus initiating the vomiting reflex, causing nausea and vomiting.

mechanism of action

Ondansetron is a selective serotonin 5-HT3 receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT3 receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone.


Low blood pressure and fainting, sudden blindness, severe constipation




Ondansetron is well absorbed after oral administration and undergoes limited first-pass metabolism.

half life

5.7 hours